| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
4.48(B) |
| Last
Volume: |
326,445 |
Avg
Vol: |
495,679 |
| 52
Week Range: |
$71.24 - $97.37 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,812 |
31,812 |
52,026 |
112,090 |
| Total Sell Value |
$2,869,033 |
$2,869,033 |
$4,659,768 |
$9,328,076 |
| Total People Sold |
4 |
4 |
5 |
9 |
| Total Sell Transactions |
11 |
11 |
16 |
30 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  White Jonathan |
Chief Science and Technology |
• – – |
2015-07-21 |
4 |
D |
$39.15 |
$23,568 |
D/D |
(602) |
25,228 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-07-20 |
4 |
AS |
$39.09 |
$191,610 |
D/D |
(4,902) |
38,188 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-07-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-07-15 |
4 |
AS |
$39.59 |
$260,092 |
D/D |
(6,569) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-07-15 |
4 |
OE |
$27.69 |
$181,863 |
D/D |
6,569 |
153,609 |
|
- |
|
| Allen Peter M |
President, Global Plasma |
• – – |
2015-07-06 |
4 |
AS |
$40.19 |
$1,225,651 |
D/D |
(30,494) |
34,102 |
|
- |
|
| Allen Peter M |
President, Global Plasma |
• – – |
2015-07-06 |
4 |
OE |
$27.28 |
$831,724 |
D/D |
30,494 |
64,596 |
|
- |
|
| White Jonathan |
Chief Science and Technology |
• – – |
2015-07-02 |
4 |
AS |
$41.14 |
$98,119 |
D/D |
(2,385) |
25,620 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-07-01 |
4 |
AS |
$41.28 |
$196,711 |
D/D |
(4,765) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-07-01 |
4 |
OE |
$27.28 |
$129,965 |
D/D |
4,765 |
151,805 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-06-22 |
4 |
AS |
$42.51 |
$208,394 |
D/D |
(4,902) |
38,188 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-06-22 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-06-15 |
4 |
AS |
$42.51 |
$279,221 |
D/D |
(6,569) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-06-15 |
4 |
OE |
$27.69 |
$181,863 |
D/D |
6,569 |
153,609 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• – – |
2015-06-10 |
4 |
AS |
$43.00 |
$258,000 |
D/D |
(6,000) |
19,104 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• – – |
2015-06-10 |
4 |
OE |
$27.50 |
$164,970 |
D/D |
6,000 |
25,104 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-06-01 |
4 |
AS |
$41.39 |
$197,214 |
D/D |
(4,765) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-06-01 |
4 |
OE |
$27.28 |
$129,965 |
D/D |
4,765 |
151,805 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-05-20 |
4 |
AS |
$41.65 |
$204,172 |
D/D |
(4,902) |
38,188 |
|
- |
|
| Lindop Christopher J |
CFO & EVP Business Development |
• – – |
2015-05-20 |
4 |
OE |
$26.32 |
$128,996 |
D/D |
4,902 |
43,090 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• – – |
2015-05-05 |
4 |
AS |
$40.08 |
$160,300 |
D/D |
(4,000) |
19,104 |
|
- |
|
| Hanlon Susan M |
VP Finance |
• – – |
2015-05-05 |
4 |
OE |
$26.47 |
$105,880 |
D/D |
4,000 |
23,104 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-05-01 |
4 |
AS |
$40.74 |
$194,139 |
D/D |
(4,765) |
147,040 |
|
- |
|
| Concannon Brian |
President & CEO |
• • – |
2015-05-01 |
4 |
OE |
$27.28 |
$129,965 |
D/D |
4,765 |
151,805 |
|
- |
|
| Selman Byron |
President, Global MarketsOffic |
• – – |
2015-04-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,993 |
|
- |
|
591 Records found
|
|
Page 20 of 24 |
|
|
1.47 (1.65%) 
